Books and Book Chapters
Books
13. Schmitz G, Endres S, GötteD (Herausgeber).
Biomarker: Bedeutung für medizinischen Fortschritt und Nutzenbewertung
Schattauer Verlag, Stuttgart, 2008;
12. Hartmann G, Endres S (Heftherausgeber).
Toll-like receptor-based drug development.
Arzneimittel-Forschung Drug Research 2006;
11.Ruß A, Endres S, Hoffmann C (Herausgeber).
Arzneimittel manual.
Börm Bruckmeier Verlag, Grünwald 2005;
10. Endres S (Herausgeber).
Facharztprüfung Innere Medizin in Fällen, Fragen und Antworten
Urban & Fischer 2003;
9. Endres S, Scriba PC (Heftherausgeber).
Pharmakotherapie in der Gastroenterologie
Deutsche Medizinische Wochenschrift 2003; 8
8. Scriba PC, Endres S (Wissenschaftliche Leitung).
Perspektiven der gastroenterologischen Pharmakotherapie
Arzneimittel-Forschung Drug Research 2002; 52(12)
7. Werdan K., Endres S (Heftherausgeber).
Zytokine und (Anti-)Zytokintherapie.
Der Internist 2001; 42(1)
6. Hartmann G, Endres S, editors.
Manual of Antisense Methodology.
Kluwer Academic Publishers, Boston 1999;
5. Scriba PC, Endres S (Heftherausgeber).
Klinische Pharmakologie: Therapie mit und gegen NO.
Der Internist 1997; 38(5)
4. Kristensen SD, Schmidt EB, De Caterina R, Endres S, editors.
Preventive Strategies in Vascular Disease: Focus on n-3 Fatty Acids.
Springer-Verlag, Berlin - Heidelberg 1995;
3. Scriba PC, Endres S (Heftherausgeber)
Klinische Forschergruppen in Deutschland.
Der Internist 1995; 36(4)
2. De Caterina R, Endres S, Kristensen SD, Schmidt EB, editors.
n-3 Fatty Acids and Vascular Disease.
Springer-Verlag, Berlin - Heidelberg 1993;
1. Endres S.
n-3 Fettsäuren und zyklische Nukleotide in der Regulation der Synthese von Interleukin-1 und Tumor-Nekrose-Faktor.
Habilitationsschrift, LMU München 1992;
Book Chapters
22. Endres S, Kobold S.
Budenosid: Pharmakologische Grundlagen. In: Miehlke S, Madisch A, editors.
Topische Steroide in der Gastroenterologie.
UNI-MED Verlag AG, Bremen, London, Boston, 2013; 12-15
21. Endres S, Anz D, Bourquin C.
Biomarker: Anwendung in der Praxis-Beispiel Gastroenterologie. In: Schmitz G, Endres S, Götte D, editors.
Biomarker: Bedeutung für medizinischen Fortschritt und Nutzenbewertung.
Schattauer, Stuttgart, New York, 2008; 115-118
20. Bourquin C, Anz D, Rothenfußer S, Endres S.
Toll-like-Rezeptoren als neue Marker und Targets der Pharmakotherapie: Schmitz G, Endres S, Götte D, editors.
Biomarker: Bedeutung für medizinischen Fortschritt und Nutzenbewertung.
Schattauer, Stuttgart, New York, 2008; 75-86
19. Endres S
Gastroenterologie. In: Endres S, editor.
Facharztprüfung Innere Medizin.
Urban & Fischer-Elsevier, München 2003; 137-219
18. Endres S, Eigler A, Hartmann G.
n-3 Polyunsaturated fatty acids and human cytokine synthese. In: Yehuda S, Mostofsky DI, editors.
n-3 Fatty Acids: Biochemistry and Behavior
Human Press Inc., Totowa, NJ, USA 1999; 609-18f
17. Endres S, Gröttrup-Wolfers E, Lorenz R, Loeschke K.
n-3 Fatty acids in inflammatory bowel disease. In: Kristensen SD, Schmidt EB, De Caterina R, Endres S, editors.
n-3 Fatty Acids: Prevention and Treatment in Vascular Disease
Springer-Verlag, Berlin - Heidelberg 1995; 181-8
16. Endres S, Eisenhut T, Sinha B.
Omega-3 fatty acids in the regulation of cytokine synthesis. In: Pownall HJ, Spector AA, Conference Cochairs.
Proceedings from the Scientific Conference on Omega-3 Fatty Acids in Nutrition, Vascular Biology, and Medicine
American Heart Association 1995; 146-151
15. Endres S, Sinha B, Eisenhut T.
w3 fatty acids in the regulation of cytokine synthesis. In: Galli C, Simoupolous AP, Tremoli E, editors.
Effects of Fatty Acids and Lipids in Health and Disease. World Rev Nutr Diet
Karger-Verlag, Basel 1994; (76)143-5
14. Endres S, Eisenhut T, Sinha B.
n-3 fatty acids and cytokines. In: De Caterina R, Endres S, Kristensen SD, Schmidt EB, editors.
n-3 Fatty Acids and Vascular Disease
Springer-Verlag, Berlin - Heidelberg 1993; 31-8
13. Endres S, Fülle HJ, Sinha B, Stoll D, Gerzer R.
Regulation of cytokine synthesis through cyclic nucleotides. In: Faist E, et al., editors.
Proceedings of the Second International Congress on the Immune Consequences of Trauma, Shock and Sepsis
Springer-Verlag, Berlin 1993; 609-12
12. Endres S, Meydani SN, Dinarello CA.
Manipulation of cytokine synthesis through dietary lipids. In: Faist E, et al., editors.
Proceedings of the Second International Congress on the Immune Consequences of Trauma, Shock and Sepsis
Springer-Verlag, Berlin 1993; 1013-6
11. Endres S.
Cytokines and their modulation by n-3 fatty acids with regard to atherogenesis. In: De Caterina R, Kristensen SD, Schmidt EB, editors.
Fish Oil and Vascular Disease
Springer-Verlag, Berlin 1992; 59-64
10. Endres S, Kaminski W, von Schacky C.
n-3 Fatty acids and the regulation of growth factors and cytokines. In: Frölich JC, von Schacky C, editors.
Clinical Pharmacology
Zuckschwerdt, München 1992; (5)98-103
9. Endres S, Meydani SN, Dinarello CA.
Effects of w-3 fatty acid supplements on ex vivo synthesis of cytokines in human volunteers. Comparison with oral aspirin and ibuprofen. In: Simopoulos AP, et al., editors.
World Rev Nutr Diet
Karger, Basel 1991; (66)401-6
8. Meydani SN, Endres S, Woods MM, Goldin BR, Soo C, Morrill-Labrode A, Dinarello CA, Gorbach SL.
Effect of oral n-3 fatty acid supplementation on the immune response of young and older women. In: Samuelsson B, et al., editors.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
Raven Press, New York 1990; (21)245-8
7. Nerad JL, Griffiths JK, van der Meer JWM, Endres S, Keusch GT, Bennish M, Dinarello CA, Cannon JG.
A simple rapid method for studying cytokine production by endotoxin-stimulated leukocytes. In: Dinarello CA, et al., editors.
Physiological and Pathophysiological Effects of Cytokines
Alan R. Liss, New York 1990; 19-24
6. Endres S, Meydani SN, Ghorbani R, Schindler R, Dempsey R, Dinarello CA.
Interleukin-2 production is suppressed by dietary n-3 fatty acids but enhanced by oral aspirin. In: Dinarello CA, et al., editors.
Physiological and Pathophysiological Effects of Cytokines
Alan R. Liss, New York 1990; 281-6
5. Shapiro AC, Meydani SN, Meydani M, Morrow F, Blumberg J, Endres S, Dinarello CA.
The effect of fish oil supplementation on plasma alpha‑tocopherol and retinol levels. In: Chandra RK, editor.
Health Effects of Fish and Fish Oils
ARTS Biomedical Publishers, St. John's, Newfoundland 1989; 537-46
4. Endres S, Dinarello CA.
Interleukin‑1 and tumor necrosis factor - mediators of the acute phase response and possible modes for their manipulation. In: Zor U, et al., editors.
Leukotrienes and Prostanoids in Health and Disease. New Trends in Lipid Mediator Research
Karger, Basel 1989; (3)114-8
3. Dinarello CA, Endres S.
Interleukin-1. In: Groopman JE, et al., editors.
Mechanisms of Action and Therapeutic Applications of Biologicals in Cancer and Immune Deficiency Disorders
Alan R. Liss, New York 1989; 201-18
2. Cannon JG, van der Meer JWM, Endres S, Lonnemann G, DinarelloCA.
Interleukin‑1 in human blood: Chloroform extraction and radioimmunoassay. In: Powanda MC, et al., editors.
Monokines and Other Non‑Lymphocytic Cytokine
Alan R. Liss, New York 1988; 373‑6
Humans taking dietary omega-3 fatty acids have decreased in vitro production of interleukin-1. In: Powanda MC, et al., editors.
Monokines and Other Non‑Lymphocytic Cytokine
Alan R. Liss, New York 1988; 153-8
